Alina Berriolo-Riedinger

4PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 18, 2023
The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients.

Hervé Ghesquières, Daphné Krzisch, Emmanuelle Nicolas-Virelizier

|Oct 20, 2023
High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma.

Vincent Camus, Pierre-Julien Viailly, Fanny Drieux

|Aug 31, 2022
A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma.

Catherine Thieblemont, Loic Chartier, Ulrich Dührsen

|Aug 30, 2021
Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study.

Vincent Camus, Cédric Rossi, Pierre Sesques

Pageof 1